GAVI documents

This GAVI Alliance Business Plan 2011-2015 describes the actions to be undertaken to achieve the 2011-2015 Strategy, while also laying out the context and challenges for the coming years.

This GAVI Alliance Board paper, approved at the December 2010 Board meeting in Rwanda, lists 12 goal-level indicators to monitor progress against GAVI's 2011-15 strategy.

The Monitoring and Evaluation Framework and Strategy is designed to contribute to meeting the GAVI Alliance’s diverse information needs, including those related to internal business processes, support to countries and overall effectiveness, efficiency and impact.

The goal of the AMC baseline study was to establish the environment prior to the AMC with baseline estimates for a selection of indicators related to the objectives of the AMC and to model counterfactual scenarios to ascertain the potential impact of the AMC vis-a-vis traditional financial and procurement strategies.

The Committee's overall assessment is that this is a credible and useful evaluation. The evaluation has yielded a number of important insights that will prove useful to the Board and Alliance as it prepares for and then implements its new strategy for the 2011-15 period.

Supporting paper 9 of the second GAVI evaluation.

The report provides contextual information on Nigeria in terms of its health and immunisation sector, and assesses the results and value add of GAVI programs in the country. The key conclusions are based on evidence gathered during a field visit to Nigeria in the week of 12 April, and desk research.

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 3 in GAVI Phase II (2006-2010). The GAVI Alliance's second strategic goal is to "Accelerate the uptake and use of underused and new vaccines and associated technologies and improve vaccine supply stability."

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 1 in GAVI Phase II (2006-2010). GAVI's Strategic Goal 1 is: "to contribute to strengthening the capacity of the health system to deliver immunisation and other health services in a sustainable manner."

List of consultations on the second GAVI evaluation.

The document sets out progress on indicators and outputs for each of the four strategic goals as listed in the Revised GAVI Alliance Strategy 2007-10 (Annex source 2).

The report provides contextual information on Mali’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country.

This annex aims to illustrate the type, nature and extent of GAVI funding to date for strategic goal 1 programmes.

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 3 in GAVI Phase II (2006-2010). GAVI's Strategic Goal 3 is: "to increase the predictability and sustainability of long-term financing for national immunisation programs."

Supporting paper 3 of the second GAVI evaluation.

Supporting paper 6 of the second GAVI evaluation.

The report provides contextual information on Bolivia’s health and immunisation sector, and assesses the results and value add of GAVI programs from country stakeholders’ perspectives.

The report provides contextual information on Uzbekistan, in terms of its health and immunisation sector and assesses the results and value add of GAVI programs in the country.

Supporting paper 7 of the second GAVI evaluation.

List of supporting papers for the second GAVI evaluation.

Supporting paper 10.2 of the second GAVI evaluation.

This report provides the detailed analysis and evaluation material for Strategic Goal (SG) 4 in GAVI Phase II (2006-2010). GAVI's SG4 is: "to increase and assess the added value of GAVI as a public private global health partnership through improved efficiency, increased advocacy and continued innovation."

Bibliography to the second GAVI evaluation.

Supporting paper 10.3 of the second GAVI evaluation.

The report provides contextual information on Bangladesh’s health and immunisation sector, and assesses the results and value add of GAVI programs in the country from the country stakeholders’ perspective.